Oral sex, cancer and death: Sexually transmitted cancers

Head and Neck Oncology

Volumn 4, Issue 1, 2012, Pages

  Upile, Tahwinder ^a,b   Jerjes, Waseem ^c,d,e,f   Al Khawalde, Mohammed ^g   Radhi, Hani ^c,d   Sudhoff, Holger ^h  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c AL YARMOUK UNIVERSITY COLLEGE   (Iraq)

^d MUSTANSIRIYAH UNIVERSITY   (Iraq)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g Royal Medical Service   (Jordan)

^h UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; DEATH; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALIGNANT TRANSFORMATION; ORAL SEXUAL CONTACT; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; TONGUE CANCER; TONSIL CANCER; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MOUTH; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 84861829388     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-4-31     Document Type: Review

References (25)

1. HPV & head and neck cancer: a descriptive update. Goon PK, Stanley MA, Ebmeyer J, Steinsträsser L, Upile T, Jerjes W, Bernal-Sprekelsen M, Görner M, Sudhoff HH, Head Neck Oncol 2009 1 36 10.1186/1758-3284-1-36 19828033
2. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C, Head Neck Oncol 2010 2 9 10.1186/1758-3284-2-9 20406474
3. Risk factors for oral and pharyngeal cancer in young adults. Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E, et al. Oral Oncol 2004 40 2 207 213 10.1016/j.oraloncology.2003.08.014 14693246
4. Changing patterns of tonsillar squamous cell carcinoma in the United States. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ, Cancer Causes Control 2000 11 6 489 495 10.1023/A:1008918223334 10880031
5. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Shiboski CH, Schmidt BL, Jordan RC, Cancer 2005 103 9 1843 1849 10.1002/cncr.20998 15772957
6. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, et al. Int J Cancer 2006 119 11 2620 2623 10.1002/ijc.22177 16991119
7. HPV infections and tonsillar carcinoma. Syrjanen S, J Clin Pathol 2004 57 5 449 455 10.1136/jcp.2003.008656 15113849
8. HPV and Its Effect on Head and Neck Cancer Prognosis. Gillison M, Clin Adv Hematol Oncol 2010 8 10 680 682 21317864
9. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication. Jerjes W, Upile T, Radhi H, Petrie A, Abiola J, Adams A, Kafas P, Callear J, Carbiner R, Rajaram K, Hopper C, Head Neck Oncol 2012 4 6 10.1186/1758-3284-4-6 22409767
10. Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Gillison M, Curr Opin Oncol 2009 21 5 439 444 10.1097/CCO. 0b013e32832f3e1b 19587593
11. The global health burden of infection-associated cancers in the year 2002. Parkin D, Int J Cancer 2006 118 12 3030 3044 10.1002/ijc.21731 16404738
12. Human papillomavirus genotype distribution in tonsil cancers. St Guily JL, Clavel C, Okas C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Léocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C, Head Neck Oncol 2011 3 1 6 10.1186/1758-3284-3-6 21299882
13. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J, Int J Oral Surg 1983 12 6 418 424 10.1016/S0300-9785(83)80033-7 6325356
14. Case-control study of human papillomavirus and oropharyngeal cancer. DSouza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. N Engl J Med 2007 356 19 1944 1956 10.1056/NEJMoa065497 17494927
15. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladstrom A, et al. Acta Otolaryngol 2005 125 12 1337 1344 10.1080/00016480510043945 16303684
16. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Kreimer AR, Clifford GM, Boyle P, Franceschi S, Cancer Epidemiol Biomarkers Prev 2005 14 2 467 475 10.1158/1055-9965.EPI-04-0551 15734974
17. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. N Engl J Med 2001 344 15 1125 1131 10.1056/ NEJM200104123441503 11297703
18. An immune reaction may be necessary for cancer development. Prehn R, Theor Biol Med Model 2006 3 6 1 9 16403216
19. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, et al. J Clin Oncol 2006 24 36 5630 5636 10.1200/JCO.2005.04.6136 17179101
20. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. J Natl Cancer Inst 2000 92 9 709 720 10.1093/jnci/92.9.709 10793107
21. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM, Otolaryngol Head Neck Surg 2001 125 1 1 9 10.1067/mhn.2001.116979 11458206
22. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, et al. Int J Cancer 2002 102 2 152 158 10.1002/ijc.10669 12385011
23. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. J Clin Oncol 2006 24 5 736 747 10.1200/JCO.2004.00.3335 16401683
24. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. J Natl Cancer Inst 2008 100 4 261 269 10.1093/jnci/djn011 18270337
25. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Gillison ML, Semin Oncol 2004 31 6 744 754 10.1053/j.seminoncol.2004.09.011 15599852